SAIC Board of Directors Declares Cash Dividend
August 30, 2024 08:25 ET
|
SAIC, Inc.
RESTON, Va., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per...
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
August 30, 2024 08:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
HOOKIPA Pharma Announces Board of Directors Changes
August 30, 2024 08:00 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Aug. 30, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its...
DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence
August 30, 2024 08:00 ET
|
DIH Technology
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation,...
Gentex Announces Third Quarter 2024 Cash Dividend
August 30, 2024 08:00 ET
|
Gentex Corporation
ZEELAND, Mich., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection...
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
August 30, 2024 08:00 ET
|
Qomolangma Acquisition Corp.
New York, NY, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the “Company”) announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC...
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 30, 2024 08:00 ET
|
Vaxart, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that on August 26, 2024, the Compensation Committee of the...
Disc Medicine to Participate in Upcoming Investor Conferences
August 30, 2024 08:00 ET
|
Disc Medicine Inc
WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of...
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September
August 30, 2024 08:00 ET
|
NewAmsterdam Pharma N.V.
NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 30, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference